Literature DB >> 10986432

Development of the placental villous tree and its consequences for fetal growth.

J Kingdom1, B Huppertz, G Seaward, P Kaufmann.   

Abstract

Co-ordinated development of the fetal villous tree of the placenta is necessary for continued fetal growth and well-being. Before fetal viability, blood vessel development within the developing immature intermediate villi (IIV) is characterized by branching angiogenesis, such that the placenta expands to produce 10-16 generations of stem villi. Once fetal viability is attained, a developmental switch occurs to form large numbers of gas-exchanging terminal villi (TV) by non-branching angiogenesis in mature intermediate villi (MIV). Several growth factors, including vascular endothelial growth factor (VEGF), placenta growth factor (PlGF), angiopoietins, and angiostatins are produced within the villi and act locally, via their receptors, to control angiogenesis. Their relative contributions to placental vascular development are not fully understood at the present time. Severe early-onset intrauterine growth restriction (IUGR) is characterized by absent/reversed end-diastolic flow velocity (ARED) in the umbilical arteries, leading to fetal hypoxia, acidosis and a substantial rise in perinatal mortality and morbidity. The placentas from such cases show a deficit in peripheral villous development, which may be perpetuated by the effects of oxygen (delivered by maternal blood into the intervillous space) upon VEGF-directed angiogenesis, the so-called 'placental hyperoxia' theory of villous maldevelopment. Trophoblast apoptosis is a significant feature of early-onset IUGR and may explain poor flow-independent transfer of nutrients to the fetus. Finally, since transgenic mouse studies highlight the importance of trophoblast-derived transcription factors for placental villous (labyrinth) development, it is possible that the villous trophoblast controls the orderly development of the underlying mesoderm and blood vessels into the fetal villi.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10986432     DOI: 10.1016/s0301-2115(00)00423-1

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  126 in total

1.  Hypoglycemia, hyperglucagonemia, and fetoplacental defects in glucagon receptor knockout mice: a role for glucagon action in pregnancy maintenance.

Authors:  Sophia Ouhilal; Patricia Vuguin; Lingguang Cui; Xiu-Quan Du; Richard W Gelling; Sandra E Reznik; Robert Russell; Albert F Parlow; Clara Karpovsky; Nanette Santoro; Maureen J Charron
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-12-13       Impact factor: 4.310

2.  Structural analysis of human placental stem and terminal villi from normal and idiopathic growth restricted pregnancies.

Authors:  Shaima M Almasry; Magda A Eldomiaty; Amr K Elfayomy; Fawzia A Habib; Maha D Safwat
Journal:  J Mol Histol       Date:  2012-03-30       Impact factor: 2.611

3.  Cell specific patterns of methylation in the human placenta.

Authors:  Ariadna Grigoriu; Jose Carlos Ferreira; Sanaa Choufani; Dora Baczyk; John Kingdom; Rosanna Weksberg
Journal:  Epigenetics       Date:  2011-03-01       Impact factor: 4.528

4.  Quantitative research of capillaries in terminal villi of mature placentae.

Authors:  Zlata Zigić; Sergije Marković; Durdica Grbesa; Suada Ramić; Almir Halilović
Journal:  Bosn J Basic Med Sci       Date:  2010-05       Impact factor: 3.363

5.  eNOS, NO, and the activation of ERK and AKT signaling at mid-gestation and near-term in an ovine model of intrauterine growth restriction.

Authors:  Juan A Arroyo; Russell V Anthony; Thomas A Parker; Henry L Galan
Journal:  Syst Biol Reprod Med       Date:  2010-02       Impact factor: 3.061

6.  Extracellular vesicles generated by placental tissues ex vivo: A transport system for immune mediators and growth factors.

Authors:  Wendy Fitzgerald; Nardhy Gomez-Lopez; Offer Erez; Roberto Romero; Leonid Margolis
Journal:  Am J Reprod Immunol       Date:  2018-05-04       Impact factor: 3.886

7.  Placental growth factor: as an early second trimester predictive marker for preeclampsia in normal and high-risk pregnancies in a Turkish population.

Authors:  Necmiye Dover; Hacer C Gulerman; Sevki Celen; Serkan Kahyaoglu; Okan Yenicesu
Journal:  J Obstet Gynaecol India       Date:  2012-11-02

8.  Pregnancy-associated plasma protein A up-regulated by progesterone promotes adhesion and proliferation of trophoblastic cells.

Authors:  Jiao Wang; Shuai Liu; Hua-Min Qin; Yue Zhao; Xiao-Qi Wang; Qiu Yan
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

9.  Adenosine A2A receptor regulates expression of vascular endothelial growth factor in feto-placental endothelium from normal and late-onset pre-eclamptic pregnancies.

Authors:  Jesenia Acurio; Kurt Herlitz; Felipe Troncoso; Claudio Aguayo; Patricio Bertoglia; Carlos Escudero
Journal:  Purinergic Signal       Date:  2016-09-30       Impact factor: 3.765

Review 10.  Complement regulation during pregnancy.

Authors:  Hector Molina
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.